Consensus MedinCell S.A.

Equities

MEDCL

FR0004065605

Real-time Euronext Paris Other stock markets 07:18:51 2024-05-06 am EDT			5-day change	1st Jan Change
14.88 ^EUR	+4.06%		+7.83%	+106.67%

Apr. 17	Medincell: share price rises following agreement with AbbVie	CF
Apr. 16	Medincell, AbbVie to Co-Develop Injectable Therapeutics	DJ

Evolution of the average Target Price on MedinCell S.A.

Price target over the last 5 years

History of analyst recommendation changes

9e04df938cf985ea7657c9c4b9befaa.Prp0OEBhQy5Xp9Sv3mb3t0V3slDpYvp0REPJBbApFPg.UYMfTjIKB080krvilATB-g0R3gW5A7QVDS77cP1iTZNb0yt5Iwl7HwD-5A~231b725a656c83c475ba26a336e8cec4

Analyst Recommendations on MedinCell S.A.

MedinCell: share price surges, broker in support	23-03-21	CF
MEDINCELL : Oddo raises its target price on the stock	23-03-21	CF

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

14.3 EUR

Average target price

17.15 EUR

Spread / Average Target

+19.93%

High Price Target

22 EUR

Spread / Highest target

+53.85%

Low Price Target

14 EUR

Spread / Lowest Target

-2.10%

Consensus detail

Consensus revision (last 18 months)

Ratings for MedinCell S.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar